Company Profile
Updated: 26-OCT-09AdnaGen AG
Non-Quoted Public Company
Ostpassage 7, Langenhagen, D-30853, Germany
()49 0511 72 59 50 50, 49 0511 72 59 50 40 fax, http://www.adnagen.com
Primary SIC: Commercial Physical & Bio Research, Primary NAICS: Research and Development in the Physical Sciences and Engineering Sciences
Description: Services: Development of molecular genetic diagnostic systems
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
OncoVista OVIT.PK Reports 287% Increase in 2Q Revenues Due to Subsidiary's Proprietary Branded Products.
Biotech Week; 11/18/2009; 871 words; ...proprietary products of our subsidiary, AdnaGen AG, are presently sold in ten countries...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...
OncoVista: AdnaGen Test Identifies Cancer Stem Cells in the Bloodstream.
Health & Beauty Close-Up; 11/13/2009; 944 words; ...Cancer Research. The Company's AdnaTest BreastCancer product developed and produced by OncoVista's German subsidiary AdnaGen AG, is presently commercially available and CE marked in Europe. The researchers were testing the theory that cancer cells...
OncoVista (OVIT) AdnaGen Test Identifies Cancer Stem Cells in the Bloodstream.
Business Wire; 11/10/2009; 1183 words; ...s wholly owned German subsidiary AdnaGen AG, is presently commercially available...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...
OncoVista Posts 2Q 2009 Results.(Financial report)
Entertainment Close-up; 11/10/2009; 480 words; ...have established with distribution companies over the past year. The branded proprietary products of our subsidiary, AdnaGen AG, are presently sold in ten countries and the United States. We expect our revenues to continue to increase as our products...
OncoVista (OVIT.PK) Reports 287% Increase in 2Q Revenues Due to Subsidiary's Proprietary Branded Products.
Business Wire; 11/5/2009; 690 words; ...proprietary products of our subsidiary, AdnaGen AG, are presently sold in ten countries...conjunction with its subsidiary, AdnaGen AG which is based in Langenhagen Germany...the-art molecular platform of AdnaGen AG. Further information on OncoVista...
Recent News Articles
- AdnaGen AG Completes Successful Financial Restructuring.
Business Wire - May 04, 2009 - AdnaGen AG and OncoVista Innovative Therapies Inc., Announce the Issuance in the U.S. of a Key Patent Related to Technology for the Detection and Analysis of Circulating Tumor Cells.
Business Wire - March 26, 2009 - OncoVista, Inc. Increases Ownership of AdnaGen AG.
Business Wire - June 18, 2008 - OncoVista Increases Its Share in AdnaGen AG.
Business Wire - December 17, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning